(2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide

C102H106Cl2N24O5 — CID 159224525

IUPAC(2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide
SMILESCOc1cccc([C@H](C)CC(=O)N2CCN(c3ncnc4[nH]c(-c5ccc(Cl)cc5)cc34)CC2)c1.C[C@H]1CN(c2ncnc3c2C=C(c2ccncc2)C3)CCN1C(=O)NCc1cccc(Cl)c1.Cc1ccc(CNC(=O)N2CCN(c3ncnc4c3C=C(c3ccncc3)C4)C[C@@H]2C)cc1.Cc1ccc(NC(=O)N2CCN(c3ncnc4c3C=C(c3ccncc3)C4)C[C@@H]2C)cn1
InChIInChI=1S/C27H28ClN5O2.C26H28N6O.C25H25ClN6O.C24H25N7O/c1-18(20-4-3-5-22(15-20)35-2)14-25(34)32-10-12-33(13-11-32)27-23-16-24(31-26(23)29-17-30-27)19-6-8-21(28)9-7-19;1-18-3-5-20(6-4-18)15-28-26(33)32-12-11-31(16-19(32)2)25-23-13-22(14-24(23)29-17-30-25)21-7-9-27-10-8-21;1-17-15-31(9-10-32(17)25(33)28-14-18-3-2-4-21(26)11-18)24-22-12-20(13-23(22)29-16-30-24)19-5-7-27-8-6-19;1-16-3-4-20(13-26-16)29-24(32)31-10-9-30(14-17(31)2)23-21-11-19(12-22(21)27-15-28-23)18-5-7-25-8-6-18/h3-9,15-18H,10-14H2,1-2H3,(H,29,30,31);3-10,13,17,19H,11-12,14-16H2,1-2H3,(H,28,33);2-8,11-12,16-17H,9-10,13-15H2,1H3,(H,28,33);3-8,11,13,15,17H,9-10,12,14H2,1-2H3,(H,29,32)/t18-;19-;2*17-/m1000/s1
InChIKeyKSCTYXHWGJYYBK-VVYQLEAPSA-N
MW1819.04 g/mol
LogP16.28
Rot. Bonds17

About (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide

(2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide (PubChem CID 159224525) has the molecular formula C102H106Cl2N24O5 and a molecular weight of 1819.04 g/mol. Its IUPAC name is (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide.

Molecular Properties

Compound Name(2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide
PubChem CID159224525
Molecular FormulaC102H106Cl2N24O5
Molecular Weight1819.04 g/mol
Exact Mass1816.82
IUPAC Name(2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide
SMILESCOc1cccc([C@H](C)CC(=O)N2CCN(c3ncnc4[nH]c(-c5ccc(Cl)cc5)cc34)CC2)c1.C[C@H]1CN(c2ncnc3c2C=C(c2ccncc2)C3)CCN1C(=O)NCc1cccc(Cl)c1.Cc1ccc(CNC(=O)N2CCN(c3ncnc4c3C=C(c3ccncc3)C4)C[C@@H]2C)cc1.Cc1ccc(NC(=O)N2CCN(c3ncnc4c3C=C(c3ccncc3)C4)C[C@@H]2C)cn1
InChIInChI=1S/C27H28ClN5O2.C26H28N6O.C25H25ClN6O.C24H25N7O/c1-18(20-4-3-5-22(15-20)35-2)14-25(34)32-10-12-33(13-11-32)27-23-16-24(31-26(23)29-17-30-27)19-6-8-21(28)9-7-19;1-18-3-5-20(6-4-18)15-28-26(33)32-12-11-31(16-19(32)2)25-23-13-22(14-24(23)29-17-30-25)21-7-9-27-10-8-21;1-17-15-31(9-10-32(17)25(33)28-14-18-3-2-4-21(26)11-18)24-22-12-20(13-23(22)29-16-30-24)19-5-7-27-8-6-19;1-16-3-4-20(13-26-16)29-24(32)31-10-9-30(14-17(31)2)23-21-11-19(12-22(21)27-15-28-23)18-5-7-25-8-6-18/h3-9,15-18H,10-14H2,1-2H3,(H,29,30,31);3-10,13,17,19H,11-12,14-16H2,1-2H3,(H,28,33);2-8,11-12,16-17H,9-10,13-15H2,1H3,(H,28,33);3-8,11,13,15,17H,9-10,12,14H2,1-2H3,(H,29,32)/t18-;19-;2*17-/m1000/s1
InChIKeyKSCTYXHWGJYYBK-VVYQLEAPSA-N
XLogP16.28
TPSA309.99 Ų
H-Bond Donors4
H-Bond Acceptors21
Rotatable Bonds17
Heavy Atoms133
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001819.04
LogP ≤ 516.28
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1021

Analyze (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide?
The IUPAC name of (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide (CID 159224525) is (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide.
What is the SMILES notation for (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide?
The canonical SMILES for (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide is COc1cccc([C@H](C)CC(=O)N2CCN(c3ncnc4[nH]c(-c5ccc(Cl)cc5)cc34)CC2)c1.C[C@H]1CN(c2ncnc3c2C=C(c2ccncc2)C3)CCN1C(=O)NCc1cccc(Cl)c1.Cc1ccc(CNC(=O)N2CCN(c3ncnc4c3C=C(c3ccncc3)C4)C[C@@H]2C)cc1.Cc1ccc(NC(=O)N2CCN(c3ncnc4c3C=C(c3ccncc3)C4)C[C@@H]2C)cn1.
What is the InChIKey of (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide?
The InChIKey is KSCTYXHWGJYYBK-VVYQLEAPSA-N. The full InChI is InChI=1S/C27H28ClN5O2.C26H28N6O.C25H25ClN6O.C24H25N7O/c1-18(20-4-3-5-22(15-20)35-2)14-25(34)32-10-12-33(13-11-32)27-23-16-24(31-26(23)29-17-30-27)19-6-8-21(28)9-7-19;1-18-3-5-20(6-4-18)15-28-26(33)32-12-11-31(16-19(32)2)25-23-13-22(14-24(23)29-17-30-25)21-7-9-27-10-8-21;1-17-15-31(9-10-32(17)25(33)28-14-18-3-2-4-21(26)11-18)24-22-12-20(13-23(22)29-16-30-24)19-5-7-27-8-6-19;1-16-3-4-20(13-26-16)29-24(32)31-10-9-30(14-17(31)2)23-21-11-19(12-22(21)27-15-28-23)18-5-7-25-8-6-18/h3-9,15-18H,10-14H2,1-2H3,(H,29,30,31);3-10,13,17,19H,11-12,14-16H2,1-2H3,(H,28,33);2-8,11-12,16-17H,9-10,13-15H2,1H3,(H,28,33);3-8,11,13,15,17H,9-10,12,14H2,1-2H3,(H,29,32)/t18-;19-;2*17-/m1000/s1.
What are the key properties of (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide?
(2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide has a molecular weight of 1819.04 g/mol, XLogP of 16.28, 17 rotatable bonds, 4 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(3-chlorophenyl)methyl]-2-methyl-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(3R)-1-[4-[6-(4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyphenyl)butan-1-one;(2S)-2-methyl-N-[(4-methylphenyl)methyl]-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide;(2S)-2-methyl-N-(6-methyl-3-pyridinyl)-4-(6-pyridin-4-yl-7H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxamide is sourced from PubChem (CID 159224525), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).